Evaluate the Efficacy and Safety of Hydrolyzed Keratin Peptide Powder on Hair Health (NCT07458828) | Clinical Trial Compass
CompletedNot Applicable
Evaluate the Efficacy and Safety of Hydrolyzed Keratin Peptide Powder on Hair Health
South Korea120 participantsStarted 2024-01-23
Plain-language summary
This study is designed to evaluate the efficacy and safety of Hydrolyzed Keratin Peptide Powder in promoting hair health in adult with mild to moderate hair damage, compared to a placebo control.
Who can participate
Age range19 Years – 60 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Male or female, aged 19 to 60 years
* Subjects with glossy scores between 1 and 3 points on the visual assessment classification and with a total hair damage score of less than 18 points based on exposure to risk factors
* Subjects who will refrain from perms or hair coloring, excluding haircuts, during the clinical study period
* Subjects who have agreed to participate in this clinical trial prior to its commencement and have signed the written informed consent form
Exclusion Criteria:
* Subjects with hair loss conditions such as androgenetic alopecia, alopecia areata, telogen effluvium, or cicatricial alopecia at Visit 1
* Subjects who have taken oral dutasteride or finasteride within 6 months prior to Visit 1
* Subjects who have consumed health functional foods (e.g., biotin) or general foods that may affect the human application study within 2 weeks prior to Visit 1
* Subjects who have applied topical steroid preparations to the scalp for one month prior to Visit 1
* Pregnancy or breastfeeding or planning pregnancy